Boehringer Ingelheim and the EFSD call for grant applications in diabetes research
(MENAFN Press) Dubai, United Arab Emirates - Wednesday, January 23rd 2013
New research programme unveiled by Boehringer Ingelheim and the European Foundation for the Study of Diabetes (EFSD) invites European diabetes research projects to apply for funding.
The Boehringer Ingelheim and EFSD diabetes partnershiphas opened submissions for diabetes research grant applications from across Europe. In a collaboration which aims to stimulate and accelerate European research in diabetes, the EFSD/Boehringer Ingelheim European Diabetes Research Programmes have dedicated more than 2.5 million euros over three years to support research projects targeting specific areas of interest.
"Diabetes affects more than 371 million people worldwide and diabetes remains undiagnosed in up to 50% of cases," said Prof. Klaus Dugi, Corporate Senior Vice President Medicine, Boehringer Ingelheim."We are delighted to partner with the EFSD on this initiative and hope the grant encourages and supports new research in the field of diabetes."
The joint diabetes grant programme will focus on two areas of interest in order to achieve the goals and objectives of the programmes and will welcome proposals which target the following:
1. Regulations of secretion and/or function of non-insulin peptides from the endocrine pancreas. (Basic research)
2. Mechanisms relating renal dysfunction to cardiovascular disease in type 2 diabetes. (Clinical Research)
The EFSD/Boehringer Ingelheim European Diabetes Research Programmeswill consider funding of basic research projects up to 100,000 euros in total for projects lasting up to 2 years, and clinical research projects up to 400,000 euros in total for projects up to 3 years in duration. Funding applications for research projects will be accepted until 1 April 2013.
"The EFSD is proud to collaborate once again with Boehringer Ingelheim on this important research initiative," said Dr. Viktor Joergens, Executive Director and Vice Director, EFSD. "Ensuring sufficient funding for diabetes research in Europe is vital and we hope that this partnership leads the way to provide invaluable contributions to diabetes research."
Commenting on the Initiative, Mr. Karim El Alaoui, Boehringer Ingelheim Managing Director for Middle East and North Africa, said "the initiative supports Boehringer Ingelheim commitment towards serving humankind through research. The MENA region has the highest comparative prevalence of diabetes equates to 11.0%,1 so we are hoping that we could implement the initiative in the Middle East region in the near future to be able to add to the disease literature of the region".
Applications are invited from single non-profit institutions or groups of institutions in Europe and will be subject to a scientific review by a specialised and independent committee. The ad hoc committee will review the grant applications on criteria such as significance, approach and innovation.
Researchers who are interested in applying for a grant can download an application form from
The deadline for submissions is 1 April 2013 and the anticipated award date is in June 2013.
About Boehringer Ingelheim
The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.As a central element of its culture, Boehringer Ingelheim pledges to act with social responsibility. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavours.In 2011, Boehringer Ingelheim achieved net sales of about 13.2 billion euro. R&D expenditure in the business area Prescription Medicines corresponds to 23.5% of its net sales.For more information please visit www.boehringer-ingelheim.com About DiabetesAn estimated 371 million people worldwide have Type 1 and Type 2 Diabetes.2 Type 2 Diabetes is the most common type, accounting for an estimated 90% of all diabetes cases.3 Diabetes is a chronic condition that occurs when the body either does not properly produce, or use, the hormone insulin.4
MENA News Headlines
|Mar 12 2014||UAE's Etisalat signs agreement with Tata ,MENAFN|
|(MENAFN) UAE's Etisalat has announced the signing of a partnership agreement with Tata Communications that will focus on media and communication vertical segment, according to the Emirates ...|
|Mar 12 2014||Dewa invests USD14b in energy-efficiency projects ,MENAFN|
|(MENAFN) UAE-based Dewa managing director and chief executive said that the authority has an estimated investment of USD14.1 billion in energy-efficiency projects and actively promotes conservation, ...|
|Mar 12 2014||US firm Hill to recover USD10 m of Libyan debt ,MENAFN|
|(MENAFN) US construction management firm Hill International has now recovered USD10 million of USD60 million invoice owed for work in conflict-ridden Libya, the company said as it announced its 2013 ...|
|Mar 12 2014||Getafe confirm Contra as new coach ,Kora|
|(MENAFN - Kora) Garcia lost his job after a run of 12 La Liga matches without a win left the side precariously placed just one point above the bottom three.
A matter of hours after announcing his ...|
|Mar 12 2014||Dubai's Arabtec to build million home in Egypt ,MENAFN|
|(MENAFN) Dubai-based Arabtec plans to build one million homes in Egypt in a USD40 billion deal that is expected to open the doors to a politically-inspired Gulf investment, according to Arabian ...|
|Mar 12 2014||La Liga Wrap: Strugglers Rayo, Malaga pick up valuable away wins ,Kora|
|(MENAFN - Kora)
In an action-packed affair at Anoeta, the hosts took the lead after just two minutes when Inigo Martinez headed home a dangerous inswinging delivery from Ruben Pardo.
Their lead ...|
|Mar 12 2014||Seedorf upbeat over Milan chances ,Kora|
|(MENAFN - Kora) Seedorf's men face a stiff task at Vicente Calderon on Tuesday after suffering a 1-0 defeat in the first leg of their last-16 tie at San Siro last month.
Milan occupy a mid-table ...|
|Mar 12 2014||UEFA Europa League Preview: AZ v Anzhi ,Kora|
|(MENAFN - Kora) Owner Suleyman Kerimov withdrew the majority of his funding from Anzhi last year, leading to a mass exodus of players that saw them slide down the Russian Premier League table.
|Mar 12 2014||JD.com valued at USD20 b in IPO ,MENAFN|
|(MENAFN) An initial public offering (IPO) has been proposed for JD.com, the Chinese ecommerce site backed by Saudi Arabia's Prince Alwaleed bin Talal, at USD20 billion worth in the second quarter of ...|
|Mar 12 2014||Championship Wrap: Reading stun Leeds, Blackpool end barren streak ,Kora|
|(MENAFN - Kora) Exactly a year to the day since his departure from Reading, McDermott watched his Leeds side follow up Saturday's 5-1 home thrashing at the hands of Bolton Wanderers with another poor ...|
|Mar 12 2014||Schumacher showing 'small, encouraging' signs ,Kora|
|(MENAFN - Kora) The seven-time Formula One world champion has been in a medically induced coma for over two months after suffering head trauma in a skiing accident on December 29.
Last week, it ...|
|Mar 12 2014||Pillay Urges Halt to Attacks Targeting Civilians ,Qatar News Agency|
|(MENAFN - Qatar News Agency) UN High Commissioner for Human Rights Navi Pillay expressed deep concern on Tuesday that civilians in South Darfur, Sudan, have been bearing the brunt of recent attacks. ...|
|Mar 12 2014||Libyan PM Zeidan Dismissed as Oil Tanker 'Breaks Blockade' ,Qatar News Agency|
|(MENAFN - Qatar News Agency) Libya's parliament has dismissed Prime Minister Ali Zeidan after a tanker laden with oil from a rebel-held port reportedly broke through a naval blockade. MPs called a ...|
|Mar 12 2014||Bulgaria's President : Great Prospects for Further Cooperation with Qatar ,Qatar News Agency|
|(MENAFN - Qatar News Agency) Bulgaria's President Rosen Plevneliev said that there is a great prospect for further cooperation between his country and the State of Qatar in various fields. Speaking ...|
|Mar 12 2014||Nsour:Israel Apologizes Over Zeiter Killing ,Qatar News Agency|
|(MENAFN - Qatar News Agency) Israel has officially apologized for the killing of Jordanian judge Raed Zeiter who was shot dead by Israeli soldiers on Monday after he had crossed the King Hussein ...|
|Mar 12 2014||Israeli Airstrike Kills 3 Palestinians in Southern Gaza ,Qatar News Agency|
|(MENAFN - Qatar News Agency) An Israeli airstrike killed three Palestinians in the southern Gaza Strip on Tuesday, an official said.
Gaza Ministry of Health spokesman Ashraf al-Qidra said that ...|
|Mar 12 2014||Qatar - NHRC Secretary General Meets IRCS Secretary General ,Qatar News Agency|
|(MENAFN - Qatar News Agency) The National Human Rights Commission (NHRC) Secretary General Mrs. Maryam bint Abdullah Al Attiyah met here Tuesday with Dr. S P Aggarwal, the Secretary General, Indian ...|
|Mar 12 2014||Administrative Development Minister Returns To Doha From Muscat ,Qatar News Agency|
|(MENAFN - Qatar News Agency) HE Minister of Administrative Development Dr. Issa Saad Al-Jafali Al-Nuaimi returned to Doha on Tuesday coming from Muscat, wrapping up a few days' visit to Oman ...|
|Mar 12 2014||Qatar - QFPSR Celebrates International Women's Day ,Qatar News Agency|
|(MENAFN - Qatar News Agency) Qatar Foundation for Protection and Social Rehabilitation (QFPSR) celebrated International Women's Day to fight violence against women, by organizing a mass programme at ...|
|Mar 12 2014||Qatar - QF Primary Health Care Center Implements Electronic HealthRecord System ,Qatar News Agency|
|(MENAFN - Qatar News Agency) Qatar Foundation for Education, Science, and Community Development (QF) and Cerner Middle East (CME), health care information technology (HIT) solution provider, ...|